Nuveen, LLC Organogenesis Holdings Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Nuveen, LLC holds 171,776 shares of ORGO stock, worth $913,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,776Holding current value
$913,848% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
129Shares Held
61.5MCall Options Held
4.3KPut Options Held
3.93K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$66.4 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$62.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$27.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$23.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$16.5 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $696M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...